KYTX logo

Kyverna Therapeutics, Inc.

KYTX
Healthcare|Biotechnology|US
$4.88
+0.27 (+5.86%)
DCF Value
$2.04
Tangible Book / Share
$2.72
Cash / Share
$3.27

Ownership Breakdown

45.3%
Float
61.8M
Shares Outstanding
28.0M
Float Shares

Major Holders (27)

Combined: 138.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Dr. Sean E. Harper (“Harper”)Individual10.50%4,523,924Nov 12, 202413D/G
Dr. Beth C. Seidenberg (“Seidenberg”)Individual10.50%4,523,924Nov 12, 202413D/G
Westlake BioPartners Fund I, L.P. (“Westlake Fund I”)Partnership8.80%3,787,940Nov 12, 202413D/G
Westlake BioPartners GP I, LLC (“Westlake GP I”)Other8.80%3,787,940Nov 12, 202413D/G
Dr. Beth C. Seidenberg ("Seidenberg")Individual7.80%4,657,257Feb 6, 202613D/G
GordonMD Global Investments LPIA, PN7.00%3,058,485Nov 17, 202513D/G
Craig D. GordonHC, IN7.00%3,058,485Nov 17, 202513D/G
GordonMD Global Investments GP LLCHC, OO7.00%3,058,485Nov 17, 202513D/G
Westlake BioPartners GP I, LLC ("Westlake GP I")Other6.30%3,787,940Feb 6, 202613D/G
Westlake BioPartners Fund I, L.P. ("Westlake Fund I")Partnership6.30%3,787,940Feb 6, 202613D/G
GordonMD Long Biased GP LLCOther6.20%2,735,783Nov 17, 202513D/G
GordonMD Long Biased Master Fund LPPartnership6.20%2,735,783Nov 17, 202513D/G
Michael P. RubinIndividual6.10%3,466,826Feb 17, 202613D/G
Orin HirschmanHC, IN5.90%3,650,000Oct 19, 202613D/G
AIGH Capital Management LLCIA, OO5.90%3,650,000Oct 19, 202613D/G
BlackRock, Inc.Holding company5.10%3,103,757Jul 29, 202613D/G
Northpond Ventures III, LPPartnership4.90%2,805,426Feb 17, 202613D/G
Northpond Ventures III GP, LLCOther4.90%2,805,426Feb 17, 202613D/G
Bain Capital Life Sciences Opportunities III, LPPartnership4.75%2,885,000Aug 14, 202613D/G
Westlake BioPartners Opportunity Fund I, L.P. (“Westlake Opportunity Fund I”)Partnership1.70%735,984Nov 12, 202413D/G
Westlake BioPartners Opportunity GP I, LLC (“Westlake Opportunity GP I”)Other1.70%735,984Nov 12, 202413D/G
Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I")Other1.50%869,317Feb 6, 202613D/G
Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity Fund I")Partnership1.50%869,317Feb 6, 202613D/G
Northpond Ventures GP, LLCOther0.80%450,000Feb 17, 202613D/G
Northpond Ventures, LPPartnership0.80%450,000Feb 17, 202613D/G
NPV Listed, LLCOther0.40%211,400Feb 17, 202613D/G
Northpond Ventures, LLCOther0.40%211,400Feb 17, 202613D/G

Insider Trades (100)

Last 4 quarters: 2,788,477 acquired · 502,190 disposed
InsiderPositionDateTypeSharesPriceValueFiling
CLARK IAN TdirectorMay 27, 2026AWARD5,093——Form 4
CLARK IAN TdirectorMay 27, 2026AWARD20,582$8.59$176.8KForm 4
Cohen Fred EdirectorMay 27, 2026AWARD5,093——Form 4
Cohen Fred EdirectorMay 27, 2026AWARD20,582$8.59$176.8KForm 4
SEIDENBERG BETH CdirectorMay 27, 2026AWARD5,093——Form 4
SEIDENBERG BETH CdirectorMay 27, 2026AWARD20,582$8.59$176.8KForm 4
Shaw Christidirector, officer: Executive ChairpersonMay 27, 2026TAX W/H4,194$8.59$36.0KForm 4
Aktar MertdirectorMay 27, 2026AWARD5,093——Form 4
Aktar MertdirectorMay 27, 2026AWARD20,582$8.59$176.8KForm 4
Martini Gregory S.Chief Financial OfficerMay 18, 2026AWARD325,000$8.54$2.8MForm 4
Martini Gregory S.May 18, 2026OTHER0——Form 4
Dac NadiaChief Commercial OfficerMay 4, 2026AWARD300,000$9.00$2.7MForm 4
Dac NadiaMay 4, 2026OTHER0——Form 4
GRASSO MARCChief Financial OfficerMar 13, 2026AWARD65,000$8.95$581.8KForm 4
GRASSO MARCChief Financial OfficerMar 13, 2026AWARD10,000——Form 4
Biddle Warner Westondirector, officer: Chief Executive OfficerMar 13, 2026AWARD350,000$8.95$3.1MForm 4
Biddle Warner Westondirector, officer: Chief Executive OfficerMar 13, 2026AWARD58,000——Form 4
GEHCHAN NAJISee RemarksMar 13, 2026AWARD105,000$8.95$939.7KForm 4
GEHCHAN NAJISee RemarksMar 13, 2026AWARD18,000——Form 4
Miller Andrew CraigFeb 24, 2026OTHER0——Form 4
Miller Andrew CraigdirectorFeb 24, 2026AWARD42,945$7.95$341.4KForm 4
Miller Andrew CraigdirectorFeb 24, 2026AWARD11,006——Form 4
Emany Sravan KumardirectorFeb 24, 2026AWARD42,945$7.95$341.4KForm 4
Emany Sravan KumardirectorFeb 24, 2026AWARD11,006——Form 4
Emany Sravan KumarFeb 24, 2026OTHER0——Form 4
Pujols MayobanexFeb 9, 2026OTHER0——Form 4
Pujols MayobanexChief Technology OfficerFeb 9, 2026AWARD300,000$8.08$2.4MForm 4
Shaw Christidirector, officer: Executive ChairpersonJan 12, 2026AWARD185,000$8.23$1.5MForm 4
Shaw Christidirector, officer: Executive ChairpersonJan 12, 2026AWARD24,301——Form 4
Shaw Christidirector, officer: Executive ChairpersonJan 12, 2026AWARD30,000——Form 4
SEIDENBERG BETH CdirectorDec 18, 2025BUY133,333$7.50$1000.0KForm 4
Westlake BioPartners Opportunity Fund I, L.P.10 percent ownerDec 18, 2025BUY133,333$7.50$1000.0KForm 4
Walker Karen MarieChief Technology OfficerDec 15, 2025OPTION EX.23,998$4.83$115.9KForm 4
Walker Karen MarieChief Technology OfficerDec 15, 2025OPTION EX.23,998$4.83$115.9KForm 4
Walker Karen MarieChief Technology OfficerDec 15, 2025SELL23,998$12.20$292.8KForm 4
GRASSO MARCChief Financial OfficerJun 30, 2025AWARD450,000$3.07$1.4MForm 4
GRASSO MARCJun 30, 2025OTHER0——Form 4
Shaw ChristidirectorMay 29, 2025AWARD65,351$2.63$171.9KForm 4
Shaw ChristidirectorMay 29, 2025AWARD16,634——Form 4
SEIDENBERG BETH Cdirector, 10 percent owner: May 29, 2025AWARD65,351$2.63$171.9KForm 4
SEIDENBERG BETH Cdirector, 10 percent owner: May 29, 2025AWARD16,634——Form 4
SPIEGELMAN DANIEL KdirectorMay 29, 2025AWARD65,351$2.63$171.9KForm 4
SPIEGELMAN DANIEL KdirectorMay 29, 2025AWARD16,634——Form 4
Aktar MertdirectorMay 29, 2025AWARD65,351$2.63$171.9KForm 4
Aktar MertdirectorMay 29, 2025AWARD16,634——Form 4
CLARK IAN TdirectorMay 29, 2025AWARD65,351$2.63$171.9KForm 4
CLARK IAN TdirectorMay 29, 2025AWARD16,634——Form 4
Cohen Fred Edirector, 10 percent owner: May 29, 2025AWARD65,351$2.63$171.9KForm 4
Cohen Fred Edirector, 10 percent owner: May 29, 2025AWARD16,634——Form 4
Biddle Warner Westondirector, officer: Chief Executive OfficerApr 11, 2024AWARD332,500$2.06$685.0KForm 4
Jones Ryan AlexanderChief Financial OfficerApr 11, 2024AWARD74,000$2.06$152.4KForm 4
Jones Ryan AlexanderChief Financial OfficerApr 11, 2025AWARD12,000——Form 4
Walker Karen MarieChief Technology OfficerApr 11, 2024AWARD80,000$2.06$164.8KForm 4
Walker Karen MarieChief Technology OfficerApr 11, 2025AWARD13,000——Form 4
Shaw ChristidirectorFeb 14, 2025AWARD38,679$3.03$117.2KForm 4
GEHCHAN NAJISee RemarksJan 22, 2025AWARD425,000$3.29$1.4MForm 4
GEHCHAN NAJIJan 22, 2025OTHER0——Form 4
Aktar MertdirectorOct 21, 2024AWARD87,741$5.20$456.3KForm 4
Aktar MertOct 21, 2024OTHER0——Form 4
Biddle Warner Westondirector, officer: Chief Executive OfficerSep 16, 2024AWARD2,579,259$6.89$17.8MForm 4
Shaw ChristidirectorSep 16, 2024AWARD66,592$6.89$458.8KForm 4
Biddle Warner WestonSep 16, 2024OTHER0——Form 4
Shaw ChristiSep 16, 2024OTHER0——Form 4
Walker Karen MarieChief Technology OfficerJun 6, 2024OPTION EX.9,636$4.42$42.6KForm 4
Walker Karen MarieChief Technology OfficerJun 6, 2024OPTION EX.9,636$4.42$42.6KForm 4
Jones Ryan AlexanderChief Financial OfficerMay 28, 2024OPTION EX.7,146$0.73$5.2KForm 4
Jones Ryan AlexanderChief Financial OfficerMay 28, 2024OPTION EX.10,870$0.73$7.9KForm 4
Jones Ryan AlexanderChief Financial OfficerMay 28, 2024OPTION EX.7,146$0.73$5.2KForm 4
Jones Ryan AlexanderChief Financial OfficerMay 28, 2024OPTION EX.10,870$0.73$7.9KForm 4
Vida Ventures, LLC10 percent ownerFeb 12, 2024CONVERSION4,523,924——Form 4
Vida Ventures, LLC10 percent ownerFeb 12, 2024BUY252,553$22.00$5.6MForm 4
Vida Ventures, LLC10 percent ownerFeb 12, 2024BUY583$22.00$12.8KForm 4
Vida Ventures, LLC10 percent ownerFeb 12, 2024CONVERSION8,830,901——Form 4
Vida Ventures, LLC10 percent ownerFeb 12, 2024CONVERSION4,401,771——Form 4
Vida Ventures, LLC10 percent ownerFeb 12, 2024CONVERSION7,356,162——Form 4
Cohen Fred Edirector, 10 percent owner: Feb 12, 2024CONVERSION4,523,924——Form 4
Cohen Fred Edirector, 10 percent owner: Feb 12, 2024CONVERSION4,401,771——Form 4
Cohen Fred Edirector, 10 percent owner: Feb 12, 2024CONVERSION8,830,901——Form 4
Cohen Fred Edirector, 10 percent owner: Feb 12, 2024CONVERSION7,356,162——Form 4
SEIDENBERG BETH Cdirector, 10 percent owner: Feb 12, 2024CONVERSION3,787,940——Form 4
SEIDENBERG BETH Cdirector, 10 percent owner: Feb 12, 2024CONVERSION735,984——Form 4
SEIDENBERG BETH Cdirector, 10 percent owner: Feb 12, 2024CONVERSION8,830,901——Form 4
SEIDENBERG BETH Cdirector, 10 percent owner: Feb 12, 2024CONVERSION4,401,771——Form 4
SEIDENBERG BETH Cdirector, 10 percent owner: Feb 12, 2024CONVERSION3,349,538——Form 4
Westlake BioPartners Fund I, L.P.10 percent ownerFeb 12, 2024CONVERSION3,787,940——Form 4
Westlake BioPartners Fund I, L.P.10 percent ownerFeb 12, 2024CONVERSION735,984——Form 4
Westlake BioPartners Fund I, L.P.10 percent ownerFeb 12, 2024CONVERSION3,349,538——Form 4
Westlake BioPartners Fund I, L.P.10 percent ownerFeb 12, 2024CONVERSION8,830,901——Form 4
Westlake BioPartners Fund I, L.P.10 percent ownerFeb 12, 2024CONVERSION4,401,771——Form 4
Bain Capital Life Sciences Investors, LLC10 percent ownerFeb 12, 2024BUY450,000$22.00$9.9MForm 4
Bain Capital Life Sciences Investors, LLC10 percent ownerFeb 12, 2024CONVERSION2,713,868——Form 4
Bain Capital Life Sciences Investors, LLC10 percent ownerFeb 12, 2024CONVERSION12,351,087——Form 4
GILEAD SCIENCES, INC.10 percent ownerFeb 12, 2024BUY910,000$22.00$20.0MForm 4
GILEAD SCIENCES, INC.10 percent ownerFeb 12, 2024CONVERSION3,216,119——Form 4
GILEAD SCIENCES, INC.10 percent ownerFeb 12, 2024CONVERSION7,746,139——Form 4
GILEAD SCIENCES, INC.10 percent ownerFeb 12, 2024CONVERSION6,890,744——Form 4
Northpond Ventures III GP, LLCother: Former 10% OwnerFeb 12, 2024CONVERSION2,805,426$0.00$28.05Form 4
Northpond Ventures III GP, LLCother: Former 10% OwnerFeb 12, 2024BUY450,000$22.00$9.9MForm 4
Northpond Ventures III GP, LLCother: Former 10% OwnerFeb 12, 2024CONVERSION12,767,776——Form 4
Liapis Stephen ConstantineFeb 7, 2024OTHER0——Form 4